3-AP in Treating Patients With Advanced Prostate Cancer
NCT00054015
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
triapine
Sponsor
Vion Pharmaceuticals